| Literature DB >> 35702307 |
Andarge Zelalem1, Kebede Abegaz2, Ameha Kebede1, Yitagele Terefe3, Jessie L Vipham4.
Abstract
The aims of this study were to determine the prevalence of Salmonella enterica (S. enterica) antimicrobial resistance based upon phenotypic assessment, and level of sanitation indicator organisms from 150 beef carcasses collected from three representative abattoirs in eastern, central, and southern Ethiopia. Samples were screened for S. enterica prevalence following the U.S. Department of Agriculture Microbiology Laboratory Guidebook (MLG) and confirmed by real-time PCR. The S. enterica isolates were phenotypically evaluated for susceptibility to a panel of 13 antimicrobials using disk diffusion method as described in Clinical and Laboratory Standard Institutes guidelines. In addition, the coliform, total coliform, and generic E. coli populations were quantified by plating onto E. coli/coliform petrifilms. A total of 45 isolates of S. enterica were confirmed using real-time PCR. The overall prevalence of S. enterica at the carcass level was 22.7% (95% CI, 16.0-30.0). However, based on the sampling points, S. enterica prevalence detected on hides was 13.3% (95% CI, 8.0-18.7), pre-evisceration was 12.0% (95% CI, 7.3-17.3), and post-evisceration was 4.7% (95% CI, 1.3-8.0). The prevalence of S. enterica was significantly lower on post-evisceration as compared to hides (p = .009) and pre-evisceration (p = .022). No differences were detected for the prevalence of S. enterica between abattoirs (p = .346). Finally, the prevalence of S. enterica was highest during the wet season (p = .011). The overall mean log CFU/cm2 ± SD of generic E. coli, coliform, and total coliform counts were 4.55 ± 0.99, 4.91 ± 1.13, and 4.98 ± 1.09, respectively. About 20% of S. enterica exhibited phenotypic multidrug resistant. The most frequently detected resistance was to Tetracycline (28.9%), followed by Streptomycin (22.2%) and Sulfisoxazole (20.0%). The data from this study highlight the need to implement interventions on improvement of sanitary practices in abattoirs.Entities:
Keywords: Salmonella enterica; abattoir; antimicrobial resistance; meat safety; pathogens
Year: 2022 PMID: 35702307 PMCID: PMC9179143 DOI: 10.1002/fsn3.2752
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 3.553
The overall S. enterica prevalence for abattoirs and sampling points on beef carcass (n = 150)
| Abattoir |
| Prevalence (%) of | |||
|---|---|---|---|---|---|
| Carcass | Hide | Pre‐evisceration | Post‐evisceration | ||
| SH01 | 78 | 21.8 (12.8–32.1)a | 10.3 (3.8–17.9) | 15.4 (7.7–24.4) | 6.4 (1.3–11.5) |
| SH02 | 40 | 27.5 (15.0–42.5)ab | 20.0 (7.5–32.5) | 12.5 (2.5–22.5) | 2.5 (0.0–7.5) |
| SH03 | 32 | 18.8 (6.3–31.3)a | 12.5 (3.1–25.0) | 3.1 (0.0–9.4) | 3.1 (0.0–9.4) |
| Total | 150 | 22.7 (16.0–30.0) | 13.3 (8.0–18.7)c | 12.0 (7.3–17.3)cd | 4.7 (1.3–8.0)e |
N, sample size. Overall prevalence of S. enterica across the sampling points that have a superscript in common is not significantly different from each other. The prevalence of S. enterica per carcass across abattoirs that have a superscript in common is not significantly different from each other.
FIGURE 1Salmonella enterica isolates distribution across different seasons and abattoirs
Results from hygiene indicator organism assessment of beef carcasses at abattoirs (n = 150)
| Abattoir | Description |
| Coliform | Total coliform | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| P1 | P2 | P3 | P1 | P2 | P3 | P1 | P2 | P3 | ||
| SH01 | Prevalence (%) | 80.8 | 73.1 | 73.1 | 78.2 | 65.4 | 66.7 | 85.9 | 84.6 | 85.9 |
|
| ||||||||||
| ≤2 | 15 (19.2) | 16 (21.9) | 21 (26.9) | 17 (21.8) | 29 (37.2) | 26 (33.3) | 11 (14.1) | 12 (15.4) | 11 (14.1) | |
| >2 to <4 | 13 (16.7) | 22 (30.1) | 20 (25.6) | 8 (10.3) | 20 (25.6) | 13 (16.7) | 7 (9.0) | 16 (20.5) | 15 (19.2) | |
| ≥4 to <6 | 38 (48.7) | 30 (41.1) | 26 (33.3) | 29 (37.2) | 12 (15.4) | 18 (23.1) | 35 (44.9) | 32 (41.0) | 31 (39.7) | |
| ≥6 | 12 (15.4) | 5 (6.8) | 11 (14.1) | 24 (30.8) | 17 (21.8) | 21 (26.9) | 25 (32.1) | 18 (23.1) | 21 (26.9) | |
| Mean ± | 4.72 ± 0.92 | 4.37 ± 0.91 | 4.61 ± 1.11 | 5.13 ± 1.13 | 4.65 ± 1.42 | 5.17 ± 1.18 | 5.20 ± 1.12 | 4.76 ± 1.20 | 5.08 ± 1.20 | |
| SH02 | Prevalence (%) | 80 | 70.0 | 75.0 | 87.5 | 82.5 | 82.5 | 95.0 | 92.5 | 90.0 |
|
| ||||||||||
| ≤2 | 8 (20.0) | 12 (30.0) | 10 (25.0) | 5 (12.5) | 7 (17.5) | 7 (17.5) | 2 (5.0) | 3 (7.5) | 4 (10.0) | |
| >2 to <4 | 12 (30.0) | 14 (35.0) | 14 (35.0) | 2 (5.0) | 5 (12.5) | 5 (12.5) | 4 (10.0) | 5 (12.5) | 5 (12.5) | |
| ≥4 to <6 | 13 (32.5) | 14 (35.0) | 16 (40.0) | 21 (52.5) | 28 (70.0) | 26 (65.0) | 21 (52.5) | 31 (77.5) | 28 (70.0) | |
| ≥6 | 7 (17.5) | – | – | 12 (30.0) | – | 2 (5.0) | 13 (32.5) | 1 (2.5) | 3 (7.5) | |
| Mean ± | 4.66 ± 1.09 | 3.91 ± 0.83 | 3.99 ± 0.71 | 5.08 ± 1.03 | 4.42 ± 0.63 | 4.44 ± 0.73 | 5.16 ± 1.07 | 4.50 ± 0.67 | 4.57 ± 0.90 | |
| SH03 | Prevalence (%) | 90.6 | 87.5 | 78.1 | 78.1 | 81.3 | 71.9 | 96.9 | 93.8 | 90.6 |
|
| ||||||||||
| ≤2 | 3 (9.4) | 4 (12.5) | 7 (21.9) | 7 (21.9) | 6 (18.8) | 9 (28.1) | 1 (3.1) | 2 (6.3) | 3 (9.4) | |
| >2 to <4 | 4 (12.5) | 4 (12.5) | 3 (9.4) | 1 (3.1) | 4 (12.5) | 3 (9.4) | 3 (9.4) | 2 (6.3) | 3 (9.4) | |
| ≥4 to <6 | 24 (75.0) | 21(65.6) | 17 (53.1) | 18 (56.3) | 15 (46.9) | 12 (37.5) | 19 (59.4) | 19 (59.4) | 17 (53.1) | |
| ≥6 | 1 (3.1) | 3 (9.4) | 5 (15.6) | 6 (18.8) | 7 (21.9) | 8 (25.0) | 9 (28.1) | 9 (28.1) | 9 (28.1) | |
| Mean ± | 4.80 ± 0.72 | 4.67 ± 0.15 | 5.15 ± 1.22 | 5.10 ± 0.93 | 4.93 ± 1.07 | 5.13 ± 1.34 | 5.24 ± 1.01 | 5.12 ± 0.96 | 5.24 ± 1.27 | |
| Overall | 91.9% (87.2–96.0) | 95.3% (92.0–98.7) | 96.7% (93.3–99.3) | |||||||
| 4.55 ± 0.99 | 4.91 ± 1.13 | 4.98 ± 1.09 | ||||||||
| 37 (24.7%) | 38 (25.3%) | |||||||||
Sampling points (P1—hide, P2—Pre‐evisceration, P3—Post‐evisceration), n (%), number (percent).
Number of samples within the acceptable ranges of E. coli limit on beef (ES1111:2019).
E. coli prevalence (95% CI).
Coliform prevalence (95% CI).
Total coliform prevalence (95% CI) at carcass level.
Overall mean ± standard deviation logCFU/cm2 for E. coli count.
Overall mean ±standard deviation logCFU/cm2 for coliform count.
Overall mean ±standard deviation logCFU/cm2 for total coliform count.
Number (percent) of pre‐evisceration samples that were within the acceptable range of microbiological limit of E. coli (ES1111:2019).
Number (percent) of post‐evisceration samples that were within the acceptable range of microbiological limit of E. coli (ES 1111:2019).
Phenotypic antimicrobial resistance of S. enterica isolates from beef samples of abattoirs
| Antibiotics | Antibiogram pattern of | ||
|---|---|---|---|
|
S
|
I
|
R
| |
| Ampicillin (AMP, 10 μg) | 37 (82.2) | 0 (0.0) | 8 (17.8) |
| Amoxicillin–clavulanate (AMC, 20/10 μg) | 45 (100) | 0 (0.0) | 0 (0.0) |
| Gentamycin (CN, 10 μg) | 45 (100) | 0 (0.0) | 0 (0.0) |
| Streptomycin (S, 10 μg) | 29 (64.4) | 6 (13.3) | 10 (22.2) |
| Tetracycline (TE, 30 μg) | 32 (71.1) | 0 (0.0) | 13 (28.9) |
| Ciprofloxacin (CIP, 5 μg) | 44 (97.8) | 1 (2.2) | 0 (0.0) |
| Nalidixic acid (NA, 30 μg) | 43 (95.6) | 2 (4.4) | 0 (0.0) |
| Meropenem (MEN, 10 μg) | 45 (100) | 0 (0.0) | 0 (0.0) |
| Trimethoprim–sulfamethoxazole (SXT, 1.25/23.75 μg) | 43 (95.6) | 0 (0.0) | 2 (4.4) |
| Chloramphenicol (C, 30 μg) | 45 (100) | 0 (0.0) | 0 (0.0) |
| Trimethoprim (W, 5 μg) | 42 (93.3) | 0 (0.0) | 3 (6.7) |
| Sulfisoxazole (S3, 250/300 μg) | 36 (80.0) | 0 (0.0) | 9 (20.0) |
| Ceftriaxone (CRO, 30 μg) | 45 (100) | 0 (0.0) | 0 (0.0) |
Abbreviations: I, intermediate; n, number of isolates; R, resistant; S, susceptible.
Phenotypic multidrug resistance of S. enterica isolates from samples of abattoirs
| Antibiotics | No of isolates (%) |
|---|---|
| AMP, S, TE, SXT, W, S3 | 2 (4.4) |
| S, TE, S3 | 7 (15.6) |
Abbreviations: AMP, Ampicillin; S, Streptomycin; S3, Sulfisoxazole; SXT, Trimethoprim–sulfamethoxazole;TE, Tetracycline; W, Trimethoprim.